Orkambi parents start ‘buyers club’ to import generic version of CF drug
Vertex’s CF drug gets label extension as pricing row continues
UK urges Vertex to accept ‘generous’ Orkambi funding offer
In a record-breaking year for pharma, which drugs were the most outstanding?
10 drugs – and their prices – which changed pharma in 2015
Biogen following move into regenerative medicine
Biogen signs $1bn gene therapy deal; CF trial shows promise